Finance

Lists
Why is 8N10 down ३.५७%?
Dive Deeper
8N10:FRA
Biosergen AB
€ ०.०४०
-३.५७%
(-०.००१५) 1D
अक्टोबर १५, ०९:५५:०१ GMT+२  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 8N10...
Open
€ ०.०४
High
€ ०.०४
Low
€ ०.०४
Mkt. cap
४.१० करोड
Volume
०.००
52-wk high
€ ४.३४
52-wk low
€ ०.०४
No. of employees
१
Open
€ ०.०४
High
€ ०.०४
Low
€ ०.०४
Mkt. cap
४.१० करोड
Volume
०.००
52-wk high
€ ४.३४
52-wk low
€ ०.०४
No. of employees
१
News stories
From web sources and news partners
About Biosergen AB
CEOTine Kold Olesen
Employees१
Founded२००४
Headquarters-
Sector-
Websitebiosergen.net
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
१.३१ लाख
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१.२७ करोड
५८.८२ लाख
५३.३२ लाख
५३.३२ लाख
Operating expense
१.२२ करोड
९६.७३ लाख
५२.३७ लाख
५२.३७ लाख
Total operating expenses
१.२२ करोड
९६.७३ लाख
५२.३७ लाख
५२.३७ लाख
Operating income
-१.२२ करोड
-९६.७३ लाख
-५२.३७ लाख
-५२.३७ लाख
Other non operating income
-
-
-
-
EBT including unusual items
-१.२२ करोड
-९६.५९ लाख
-५२.४४ लाख
-५२.४४ लाख
EBT excluding unusual items
-१.२२ करोड
-९६.५९ लाख
-५२.४४ लाख
-५२.४४ लाख
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-५.३७ लाख
३७.९१ लाख
-९५.५० हजार
-९५.५० हजार
Net income
-१.२२ करोड
-९६.५९ लाख
-५२.४४ लाख
-५२.४४ लाख
Net profit margin
-
-
-
-
Earnings per share
-५.००
-
-
-
Interest and investment income
२२.०० हजार
१८.०० हजार
-
-
Interest expense
-
-४.०० हजार
-७.५० हजार
-७.५० हजार
Net interest expenses
२२.०० हजार
१४.०० हजार
-७.५० हजार
-७.५० हजार
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू